ANDA Sponsors Face Tight Controls On Meetings With US FDA After CR Letters
Meetings are intended to help generic sponsors understand deficiencies, but agency won't let them run past 30 minutes.
Meetings are intended to help generic sponsors understand deficiencies, but agency won't let them run past 30 minutes.